Engraftment of Mouse Embryonic Stem Cells Differentiated by Default Leads to Neuroprotection, Behaviour Revival and Astrogliosis in Parkinsonian Rats

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Tripathy, Debasmita ^a   Haobam, Reena ^a,b   Nair, Ranju ^a,c   Mohanakumar, Kochupurackal P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b MANIPUR UNIVERSITY   (India)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CELL MARKER; CELL PROTEIN; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN IBA 1; PROTEIN LMX1B; PROTEIN RET; TRANSCRIPTION FACTOR PITX3; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; BEHAVIOR DISORDER; BODY EQUILIBRIUM; CELL DIFFERENTIATION; CELL LOSS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYONIC STEM CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; THERAPY EFFECT; UPREGULATION;

AMPHETAMINE; ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; GLIOSIS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROSCOPY, PHASE-CONTRAST; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; POLYMERASE CHAIN REACTION; RATS; SEROTONIN; SUBSTANTIA NIGRA;

EID: 84884169449     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072501     Document Type: Article

References (55)

1. Annett LE, Martel FL, Rogers DC, Ridley RM, Baker HF, et al. (1994) Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 125: 228-246.
2. Lindvall O, Kokaia Z, (2009) Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 30: 260-267.
3. Steinbeck JA, Koch P, Derouiche A, Brüstle O, (2012) Human embryonic stem cell-derived neurons establish region-specific, long-range projections in the adult brain. Cell Mol Life Sci 69: 461-470.
4. Mendez I, Sanchez-Pernaute R, Cooper O, Vinuela A, Ferrari D, et al. (2005) Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128: 1498-1510.
5. Jin HJ, Nam HY, Bae YK, Kim SY, Im IR, et al. (2010) GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells. Cell Mol Life Sci 67: 1845-1858.
6. Nizzardo M, Simone C, Falcone M, Locatelli F, Riboldi G, et al. (2010) Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells. Cell Mol Life Sci 67: 3837-3847.
7. Rössler R, Boddeke E, Copray S, (2010) Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. Neuroscience 170: 417-428.
8. Deleidi M, Cooper O, Hargus G, Levy A, Isacson O, (2011) Oct4-induced reprogramming is required for adult brain neural stem cell differentiation into midbrain dopaminergic neurons. PLoS One 6: e19926.
9. Ostenfeld T, Caldwell MA, Prowse KR, Linskens MH, Jauniaux E, et al. (2000) Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol 164: 215-226.
10. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI, (1995) Embryonic stem cells express neuronal properties in vitro. Dev Biol 168: 342-357.
11. Kim JH, Auerbach JM, Rodríguez-Gómez JA, Velasco I, Gavin D, et al. (2002) Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418: 50-56.
12. Okita K, Yamanaka S, (2006) Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther 1: 103-111.
13. Tropepe V, Hitoshi S, Sirard C, Mak TW, Rossant J, et al. (2001) Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 30: 65-78.
14. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. 4th edn. (New York: Academic Press).
15. Ungerstedt U, Arbuthnott GW, (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24: 485-493.
16. Borlongan CV, Sanberg PR, (1995) Elevated body swing test: A new behavioural parameter for rats with 6-OHDA induced parkinsonism. J Neurosci 15: 5372-5378.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
18. Muralikrishnan D, Mohanakumar KP, (1998) Neuroprotection by bromocriptine against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. FASEB J 12: 905-912.
19. Watmuff B, Pouton CW, Haynes JM, (2012) In vitro maturation of dopaminergic neurons derived from mouse embryonic stem cells: implications for transplantation. PLoS One 7: e31999.
20. Hemmati-Brivanlou A, Melton D, (1997) Vertebrate embryonic cells will become nerve cells unless told otherwise. Cell 88: 13-17.
21. Lenka N, Ramasamy SK, (2007) Neural induction from ES cells portrays default commitment but instructive maturation. PLoS One 12: e1349.
22. Riebeling C, Schlechter K, Buesen R, Spielmann H, Luch A, et al. (2011) Defined culture medium for stem cell differentiation: applicability of serum-free conditions in the mouse embryonic stem cell test. Toxicol In Vitro 25: 914-921.
23. Engberg N, Kahn M, Petersen DR, Hansson M, Serup P, (2010) Retinoic acid synthesis promotes development of neural progenitors from mouse embryonic stem cells by suppressing endogenous, Wnt-dependent nodal signaling. Stem Cells 28: 1498-1509.
24. Rowland JW, Lee JJ, Salewski RP, Eftekharpour E, Kooy DV, et al. (2011) Generation of neural stem cells from embryonic stem cells using the default mechanism: In vitro and in vivo characterization. Stem Cells Dev 20: 1829-1845.
25. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, et al. (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-391.
26. Chambers I, Colby D, Robertson M, Nichols J, Lee S, et al. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
27. Shafit-Zagardo B, Kress Y, Zhao ML, Lee SC, (1999) A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions. J Neurochem 73: 2531-2537.
28. Morizane A, Darsalia V, Guloglu MO, Hjalt T, Carta M, et al. (2010) A simple method for large-scale generation of dopamine neurons from human embryonic stem cells. J Neurosci Res 88: 3467-3478.
29. Nunes I, Tovmasian LT, Silva RM, Burke RE, Goff SP, (2003) Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc Natl Acad Sci U S A 100: 4245-4250.
30. Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T, (2006) Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease. Brain Res Rev 52: 244-256.
31. Blandini F, Cova L, Armentero MT, Zennaro E, Levandis G, et al. (2010) Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant 19: 203-217.
32. Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, et al. (2010) Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6- OHDA-lesioned rats. Stem Cells Dev 19: 1017-1023.
33. Galpern WR, Frim DM, Tatter SB, Altar CA, Beal MF, et al. (1996) Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. Cell Transplant 5: 225-232.
34. Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, et al. (2010) Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Brain 133: 189-204.
35. Doi D, Morizane A, Kikuchi T, Onoe H, Hayashi T, et al. (2012) Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ES-derived neural cells in a primate model of Parkinson's disease. Stem Cells 30: 935-945.
36. Xiong N, Cao X, Zhang Z, Huang J, Chen C, et al. (2010) Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats. Biol Blood Marrow Transplant 16: 1519-1529.
37. Xiong N, Zhang Z, Huang J, Chen C, Zhang Z, et al. (2011) VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther 18: 394-402.
38. Saravanan KS, Sindhu KM, Mohanakumar KP, (2005) Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease. Brain Res 1049: 147-155.
39. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, et al. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306.
40. Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, et al. (2006) Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine. Pharmacol Biochem Behav 84: 321-329.
41. Goren B, Kahveci N, Eyigor O, Alkan T, Korfali E, et al. (2005) Effects of intranigral vs. Intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model. Surg Neurol 64: S33-41.
42. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F, (1993) GDNF: a glial cell line derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
43. Fathi F, Altiraihi T, Mowla SJ, Movahedin M, (2010) Transplantation of retinoic acid treated murine embryonic stem cells and behavioural deficit in Parkinsonian rats. Indian J Med Res 131: 536-544.
44. Sindhu KM, Saravanan KS, Mohanakumar KP, (2005) Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion. Brain Res 1051: 25-34.
45. Li B, Bedard K, Sorce S, Hinz B, Dubois-Dauphin M, et al. (2009) NOX4 expression in human microglia leads to constitutive generation of reactive oxygen species and to constitutive IL-6 expression. J Innate Immun 1: 570-581.
46. Michel-Monigadon D, Nerrie're-Daguin V, Lévèque X, Plat M, Venturi E, et al. (2010) Minocycline promotes long-term survival of neuronal transplant in the brain by inhibiting late microglial activation and T-cell recruitment. Transplantation 89: 816-823.
47. Praet J, Reekmans K, Lin D, De Vocht N, Bergwerf I, et al. (2012) Cell type-associated differences in migration, survival and immunogenicity following grafting in CNS tissue. Cell Transplant 21: 1867-1881.
48. Zhou H, Chen S, Wang W, Wang Z, Wu X, et al. (2012) Nanog inhibits lipopolysaccharide induced expression of pro-inflammatory cytokines by blocking NF-κB transcriptional activity in rat primary microglial cells. Mol Med Report 5: 842-846.
49. Barroso-Chinea P, Cruz-Muros I, Aymerich MS, Rodriguez-Diaz M, Afonso-Oramas D, et al. (2005) Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells. Eur J Neurosci 21: 1815-1827.
50. Lei Z, Jiang Y, Li T, Zhu J, Zeng S, (2011) Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson's disease. J Neuropathol Exp Neurol 70: 736-747.
51. Love S, Plaha P, Patel NK, Hotton GR, Brooks DJ, et al. (2005) Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nature Med 11: 703-704.
52. Brederlau A, Correia AS, Anisimov SV, Elmi M, Paul G, et al. (2006) Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24: 1433-1440.
53. Ko JY, Lee HS, Park CH, Koh HC, Lee YS, et al. (2009) Conditions for tumor-free and dopamine neuron-enriched grafts after transplanting human ES cell-derived neural precursor cells. Mol Ther 17: 1761-1770.
54. Lonardo E, Parish CL, Ponticelli S, Marasco D, Ribeiro D, et al. (2010) A small synthetic cripto blocking Peptide improves neural induction, dopaminergic differentiation, and functional integration of mouse embryonic stem cells in a rat model of Parkinson's disease. Stem Cells 28: 1326-1337.
55. Wang Y, Yang D, Song L, Li T, Yang J, et al. (2012) Mifepristone inducible caspase-1 expression in mouse embryonic stem cells eliminates tumor formation but spares differentiated cells in vitro and in vivo. Stem Cells 30: 169-179.